Eli Lilly enters into $960 million deal with Rigel Pharma to develop autoimmune therapy
Under the deal, Lilly will foot the costs of global commercialisation for the therapy, R552, and Rigel will have the right to…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.